This is an open-label pilot study to test procedures for determining the safety and efficacy of the aminoglycoside, tobramycin, for inhalation in patients with pulmonary tuberculosis. Tobramycin will be administered as a single drug in the form of an aerosol for the first five days of therapy and the rate at which mycobacterium tuberculosis is eradicated from the sputum will be determined.
Showing the most recent 10 out of 553 publications